drugset / Trial / NCT02490345

Gabapentin as Adjunctive Treatment for Postoperative Pain Control

NCT02490345

Phase 1 Completed 13 enrolled Indiana University
RandomizedParallel-groupTriple-blindTreatment

Summary

The specific aims of this research study are to use 600 mg gabapentin as an adjunctive treatment for acute postoperative pain control in order to reduce postoperative opiate consumption and improve postoperative pain control.

Timeline

Start
2015-10
Primary completion
2017-06-29
Completion
2017-06-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 600 mg Oral

Indications